定量特征辅助慢性淋巴细胞白血病进展的诊断评估
本文评述El Hussein、Chen等人在《病理学杂志》提出的算法流程,利用全切片图像分析辅助病理医生评估慢性淋巴细胞白血病(CLL)进展。核心是从卷积神经网络分割的细胞核中计算一组定量描述符(生物标志物),输入机器学习算法对CLL进展阶段进行分类。此类工作有助于将基于组织切片和血涂片形态学分析的自动化诊断系统整合进临床实验室工作流。
要点
- 定量特征可增加几何、颜色、纹理变量的客观性与观察者间一致性。
- 核心流程为卷积神经网络分割细胞核后计算定量描述符并输入机器学习分类。
- 该方法有望推动基于形态学分析的自动化诊断系统进入临床实验室工作流。
核心结论
- 基于全切片图像分析的算法流程可辅助病理医生评估慢性淋巴细胞白血病(CLL)的进展阶段。
研究设计与样本
- 本文为对El Hussein、Chen等人在《病理学杂志》发表论文的评述,原文提出利用组织样本全切片图像分析的算法流程。
主要发现
- 流程核心为从卷积神经网络分割的细胞核中计算一组基于临床实践且可重复计算的定量描述符(生物标志物)。
- 这些定量描述符作为机器学习算法的输入,用于对CLL进展的某一阶段进行分类。
临床怎么用
- 该方法可增加病理医生视觉判读的几何、颜色或纹理变量的客观性与观察者间一致性。
- 此类工作有助于将基于组织切片和血涂片形态学分析的自动化诊断系统整合进临床实验室工作流。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The use of artificial intelligence methods in the image-based diagnostic assessment of hematological diseases is a growing trend in recent years. In these methods, the selection of quantitative features that describe cytological characteristics plays a key role. They are expected to add objectivity and consistency among observers to the geometric, color, or texture variables that pathologists usually interpret from visual inspection. In a recent paper in The Journal of Pathology, El Hussein, Chen et al proposed an algorithmic procedure to assist pathologists in the diagnostic evaluation of chronic lymphocytic leukemia (CLL) progression using whole-slide image analysis of tissue samples. The core of the procedure was a set of quantitative descriptors (biomarkers) calculated from the segmentation of cell nuclei, which was performed using a convolutional neural network. These biomarkers were based on clinical practice and easily calculated with reproducible tools. They were used as input to a machine learning algorithm that provided classification in one of the stages of CLL progression. Works like this can contribute to the integration into the workflow of clinical laboratories of automated diagnostic systems based on the morphological analysis of histological slides and blood smears. © 2021 The Pathological Society of Great Britain and Ireland.
引用
- Merino A, Rodellar J. Quantitative features to assist in the diagnostic assessment of chronic lymphocytic leukemia progression†. J Pathol. 2022. PMID: 34928523. doi:10.1002/path.5858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。